Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Search by expertise, name or affiliation
Emerging drugs for eosinophilic esophagitis
Emily Kern,
Ikuo Hirano
*
*
Corresponding author for this work
Medicine, Gastroenterology Division
Research output
:
Contribution to journal
›
Review article
›
peer-review
9
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Emerging drugs for eosinophilic esophagitis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Adrenal Cortex Hormones
5%
Angiotensin Receptor Antagonists
7%
Asthma
5%
Deglutition Disorders
7%
Dilatation
5%
Eosinophilic Esophagitis
100%
Esophagus
6%
Expert Testimony
7%
Food
9%
Gastrointestinal Diseases
7%
Hypersensitivity
5%
Immunologic Factors
7%
Immunotherapy
6%
Inflammatory Bowel Diseases
6%
Interleukin-13
8%
Interleukin-5
7%
Leukotriene Antagonists
9%
Mast Cells
13%
Natural History
7%
Pharmaceutical Preparations
29%
Phase III Clinical Trials
8%
Physicians
8%
Prescriptions
5%
Prostaglandin D2
9%
Steroids
5%
Therapeutics
9%
United States Food and Drug Administration
14%